# Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)

> **NCT00967499** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 239 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT00967499
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-13
- **Primary completion:** 2009-12-18
- **Final completion:** 2009-12-18
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967499, "Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00967499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*